Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven

Abstract

SUMMARY OBJECTIVE Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is mostly due to the control of other cardiovascular risk factors. The objective of our study was to analyze the dyslipidemia control in two diabetes cohorts. METHODS Patients from two distinct cohorts were studied, 173 patients from the BHS (Brasília Heart Study) and 222 patients from the BDS (Brazilian Diabetes Study). The data on dyslipidemia control were studied in both different populations. All patients had diabetes. RESULTS There are significant differences concerning comorbidities between the LDL-C and BDS groups. The average glycated hemoglobin is of 8.2 in the LDL-C > 100 group in comparison with 7.7 and 7.5 in the 70-100 and < 70 groups, respectively (p = 0.024). There is a higher percentage of hypertensive patients with LDL between 70-100 (63.9%), when comparing the < 70 and > 100 groups (54.3% and 54.9%, respectively; p = 0.005). Diastolic pressure is higher in the group with LDL > 100, with an average of 87 mmHg, in comparison with 82.6 mmHg and 81.9 mmHg in the 70-100 and < 70 groups, respectively (p = 0.019). The group with LDL > 100 has the greatest percentage of smokers (8.7%) in comparison with the groups with LDL between 70-100 and < 70 (5.6% and 4.3%, respectively; p = 0.015). There is also a difference in the previous incidence of coronaropathy. In the group with LDL < 70, 28.3% of patients had already experienced a previous infarction, compared with 11.1% and 10.6% in the 70-100 and > 100 groups, respectively (p < 0.001). CONCLUSIONS The data in our study have shown that the dyslipidemia control in diabetic patients is inadequate and there is a tendency of direct association between lack of blood glucose control and lack of dyslipidemia control, in addition to the association with other cardiovascular risk factors, such as diastolic hypertension and smoking. This worsened control might be related to the plateau in the descending curve of mortality, and investments in this regard can improve the cardiovascular health in diabetic patients.

Children First Study II: an educational programme on cardiovascular prevention in public schools can reduce parents' cardiovascular risk

“…Perhaps high-income population groups have greater access to healthier foods such as fruits, vegetables, and low-fat alternatives. Indeed, a Brazilian study analyzed the treatment for dyslipidemia among patients with diabetes and observed that people with higher socioeconomic levels have better follow-up by private or insurance doctors, possibly explaining better health outcomes 16 .…”

Frequency and factors associated with dyslipidemia among people with type 2 Diabetes Mellitus / Frequência e fatores associados à dislipidemia entre pessoas com diabetes mellitus tipo 2

“…These factors make it difficult to reach desirable glycemic and lipid levels and increase cardiovascular risk. 2,22 In view of the above, there is a need to clarify to these patients the importance of adopting lifestyle changes, such as physical exercise and smoking cessation, as well as the recognition and ways to deal with risk factors to improve disease management. Although the variable alcohol consumption did not show sta-tistical significance, it is important to inform the patient about the harm that excessive alcohol consumption can cause, such as increased risk of hypertriglyceridemia.…”

“…When poorly controlled, DM2 also affects the lipid metabolism of the patient with the disease and can lead to dyslipidemia. [1][2][3] Added to this, the person with diabetes also tends to have an accumulation of adiposity that, in turn, generates a pro--inflammatory state, insulin resistance, and increases the risk of developing atherosclerosis and other major cardiovascular complications. Such an imbalance can lead to dysregulation of the immune system, facilitating infection of the patient by infectious diseases, such as COVID-19.…”

Evaluation of The Relationships of Liraglutite, Red Yeast Rice And Atorvastatin With Metabolic Parameters In Rats Feed With A High-Fat Diet

“…Cardiovascular and cerebrovascular diseases caused by atherosclerosis as a result of dyslipidemia are the leading causes of death worldwide. Dyslipidemia and diabetes mellitus are one of the most common causes of atherosclerosis worldwide [1]. The TyG index, which is calculated to predict these diseases that cause serious mortality and morbidity, is both practical and advantageous in that it can be scanned in the entire population [2].…”